https://stock.noler.com/us/stock/aratana-therapeutics-inc https://stock.noler.com/us/stock/aratana-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/aratana-therapeutics-inc/accounts-receivable https://stock.noler.com/us/stock/aratana-therapeutics-inc/accretion-expense https://stock.noler.com/us/stock/aratana-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/aratana-therapeutics-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/aratana-therapeutics-inc/accrued-royalties-current https://stock.noler.com/us/stock/aratana-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/aratana-therapeutics-inc/acquired-intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/aratana-therapeutics-inc/acquisition-consideration-transferred https://stock.noler.com/us/stock/aratana-therapeutics-inc/acquisition-consideration-transferred-equity-interests-issued-and-issuable https://stock.noler.com/us/stock/aratana-therapeutics-inc/acquisition-consideration-transferred-liabilities-incurred https://stock.noler.com/us/stock/aratana-therapeutics-inc/acquisition-consideration-transferred-other https://stock.noler.com/us/stock/aratana-therapeutics-inc/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/aratana-therapeutics-inc/acquisition-contingent-consideration-arrangements-change-in-the-range-of-outcomes-contingent-consideration-liability-value-high https://stock.noler.com/us/stock/aratana-therapeutics-inc/acquisition-contingent-consideration-arrangements-range-of-outcomes-value-high https://stock.noler.com/us/stock/aratana-therapeutics-inc/acquisition-contingent-consideration-liability https://stock.noler.com/us/stock/aratana-therapeutics-inc/acquisition-contingent-consideration-liability-current https://stock.noler.com/us/stock/aratana-therapeutics-inc/acquisition-contingent-consideration-liability-noncurrent https://stock.noler.com/us/stock/aratana-therapeutics-inc/acquisitions https://stock.noler.com/us/stock/aratana-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/aratana-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/aratana-therapeutics-inc/amortization https://stock.noler.com/us/stock/aratana-therapeutics-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/aratana-therapeutics-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/aratana-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/aratana-therapeutics-inc/aoci https://stock.noler.com/us/stock/aratana-therapeutics-inc/asset-impairment-charges https://stock.noler.com/us/stock/aratana-therapeutics-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/aratana-therapeutics-inc/available-for-sale-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/aratana-therapeutics-inc/available-for-sale-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/aratana-therapeutics-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/aratana-therapeutics-inc/available-for-sale-gross-unrealized-loss https://stock.noler.com/us/stock/aratana-therapeutics-inc/available-for-sale-securities https://stock.noler.com/us/stock/aratana-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/aratana-therapeutics-inc/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/aratana-therapeutics-inc/business-acquisitions-pro-forma-revenue https://stock.noler.com/us/stock/aratana-therapeutics-inc/buybacks-payments-for-repurchase-of-equity https://stock.noler.com/us/stock/aratana-therapeutics-inc/buybacks-share-repurchases https://stock.noler.com/us/stock/aratana-therapeutics-inc/buybacks-shares-repurchased https://stock.noler.com/us/stock/aratana-therapeutics-inc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/aratana-therapeutics-inc/buybacks-treasury-stock-cost https://stock.noler.com/us/stock/aratana-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/aratana-therapeutics-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/aratana-therapeutics-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/aratana-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/aratana-therapeutics-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/aratana-therapeutics-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/aratana-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/aratana-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/aratana-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/aratana-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/aratana-therapeutics-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/aratana-therapeutics-inc/construction-in-progress-gross https://stock.noler.com/us/stock/aratana-therapeutics-inc/contract-liability https://stock.noler.com/us/stock/aratana-therapeutics-inc/contract-with-customer-liability-change-in-timeframe-performance-obligation-satisfied-revenue-recognized https://stock.noler.com/us/stock/aratana-therapeutics-inc/contract-with-customer-liability-cumulative-catch-up-adjustment-to-revenue-change-in-estimate-of-transaction-price https://stock.noler.com/us/stock/aratana-therapeutics-inc/contract-with-customer-liability-cumulative-catch-up-adjustment-to-revenue-change-in-measure-of-progress https://stock.noler.com/us/stock/aratana-therapeutics-inc/contract-with-customer-liability-cumulative-catch-up-adjustment-to-revenue-modification-of-contract https://stock.noler.com/us/stock/aratana-therapeutics-inc/contract-with-customer-liability-increase-decrease-for-contract-acquired-in-business-combination https://stock.noler.com/us/stock/aratana-therapeutics-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/aratana-therapeutics-inc/convertible-preferred-dividends-net-of-tax https://stock.noler.com/us/stock/aratana-therapeutics-inc/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/aratana-therapeutics-inc/cost-of-goods-sold https://stock.noler.com/us/stock/aratana-therapeutics-inc/cost-of-revenue https://stock.noler.com/us/stock/aratana-therapeutics-inc/costs-and-expenses https://stock.noler.com/us/stock/aratana-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/aratana-therapeutics-inc/current-assets https://stock.noler.com/us/stock/aratana-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/aratana-therapeutics-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/aratana-therapeutics-inc/debt-convertible-conversion-ratio https://stock.noler.com/us/stock/aratana-therapeutics-inc/debt-face-amount https://stock.noler.com/us/stock/aratana-therapeutics-inc/debt-interest-rate-effective-percentage https://stock.noler.com/us/stock/aratana-therapeutics-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/aratana-therapeutics-inc/debt-issuance-costs https://stock.noler.com/us/stock/aratana-therapeutics-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/aratana-therapeutics-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/aratana-therapeutics-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/aratana-therapeutics-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/aratana-therapeutics-inc/debt-unamortized-discount https://stock.noler.com/us/stock/aratana-therapeutics-inc/debt-unamortized-discount-premium-net https://stock.noler.com/us/stock/aratana-therapeutics-inc/debt-unused-borrowing-capacity-amount https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-finance-costs-gross https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-finance-costs-net https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-income-taxes-and-tax-credits https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-offering-costs https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-revenue https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-revenue-recognized https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-tax-assets-net-current https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-tax-assets-tax-deferred-expense https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-tax-liabilities-current https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/aratana-therapeutics-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/aratana-therapeutics-inc/depreciation https://stock.noler.com/us/stock/aratana-therapeutics-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/aratana-therapeutics-inc/derivative-assets https://stock.noler.com/us/stock/aratana-therapeutics-inc/derivative-notional-amount https://stock.noler.com/us/stock/aratana-therapeutics-inc/derivative-number-of-instruments-held https://stock.noler.com/us/stock/aratana-therapeutics-inc/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/aratana-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/aratana-therapeutics-inc/dilutive-shares https://stock.noler.com/us/stock/aratana-therapeutics-inc/dividends-common-stock https://stock.noler.com/us/stock/aratana-therapeutics-inc/dividends-preferred-stock-stock https://stock.noler.com/us/stock/aratana-therapeutics-inc/due-from-officers-or-stockholders-current https://stock.noler.com/us/stock/aratana-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/aratana-therapeutics-inc/effect-of-exchange-rate-on-cash https://stock.noler.com/us/stock/aratana-therapeutics-inc/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/aratana-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/aratana-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/aratana-therapeutics-inc/eps https://stock.noler.com/us/stock/aratana-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/aratana-therapeutics-inc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/aratana-therapeutics-inc/fair-value-inputs-discount-for-lack-of-marketability https://stock.noler.com/us/stock/aratana-therapeutics-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/aratana-therapeutics-inc/financial-liabilities-fair-value-disclosure https://stock.noler.com/us/stock/aratana-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/aratana-therapeutics-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/aratana-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/aratana-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/aratana-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/aratana-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/aratana-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/aratana-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/aratana-therapeutics-inc/finite-lived-intangible-assets-foreign-currency-translation-gain-loss https://stock.noler.com/us/stock/aratana-therapeutics-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/aratana-therapeutics-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/aratana-therapeutics-inc/finite-lived-intangible-assets-translation-adjustments https://stock.noler.com/us/stock/aratana-therapeutics-inc/finitelived-intangible-assets-acquired https://stock.noler.com/us/stock/aratana-therapeutics-inc/foreign-pretax-income https://stock.noler.com/us/stock/aratana-therapeutics-inc/form-d-stocks https://stock.noler.com/us/stock/aratana-therapeutics-inc/furniture-and-fixtures-gross https://stock.noler.com/us/stock/aratana-therapeutics-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/aratana-therapeutics-inc/gain-loss-on-sale-of-stock-in-subsidiary-or-equity-method-investee https://stock.noler.com/us/stock/aratana-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/aratana-therapeutics-inc/goodwill https://stock.noler.com/us/stock/aratana-therapeutics-inc/goodwill-acquired https://stock.noler.com/us/stock/aratana-therapeutics-inc/goodwill-foreign-currency-translation-gain-loss https://stock.noler.com/us/stock/aratana-therapeutics-inc/goodwill-gross https://stock.noler.com/us/stock/aratana-therapeutics-inc/goodwill-impaired-accumulated-impairment-loss https://stock.noler.com/us/stock/aratana-therapeutics-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/aratana-therapeutics-inc/goodwill-translation-adjustments https://stock.noler.com/us/stock/aratana-therapeutics-inc/gross-profit https://stock.noler.com/us/stock/aratana-therapeutics-inc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/aratana-therapeutics-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/aratana-therapeutics-inc/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/aratana-therapeutics-inc/income-tax https://stock.noler.com/us/stock/aratana-therapeutics-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/aratana-therapeutics-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/aratana-therapeutics-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/aratana-therapeutics-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/aratana-therapeutics-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/aratana-therapeutics-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/aratana-therapeutics-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/aratana-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/aratana-therapeutics-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/aratana-therapeutics-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/aratana-therapeutics-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/aratana-therapeutics-inc/indefinite-lived-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/aratana-therapeutics-inc/insider-transactions-other https://stock.noler.com/us/stock/aratana-therapeutics-inc/insider-transactions-preferred https://stock.noler.com/us/stock/aratana-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/aratana-therapeutics-inc/insider-transactions-swaps-forwards-futures https://stock.noler.com/us/stock/aratana-therapeutics-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/aratana-therapeutics-inc/interest-expense https://stock.noler.com/us/stock/aratana-therapeutics-inc/interest-expense-on-debt https://stock.noler.com/us/stock/aratana-therapeutics-inc/interest-income-other https://stock.noler.com/us/stock/aratana-therapeutics-inc/interest-paid https://stock.noler.com/us/stock/aratana-therapeutics-inc/interest-paid-net https://stock.noler.com/us/stock/aratana-therapeutics-inc/interest-payable-current https://stock.noler.com/us/stock/aratana-therapeutics-inc/inventory https://stock.noler.com/us/stock/aratana-therapeutics-inc/inventory-adjustments https://stock.noler.com/us/stock/aratana-therapeutics-inc/inventory-finished-goods https://stock.noler.com/us/stock/aratana-therapeutics-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/aratana-therapeutics-inc/inventory-for-long-term-contracts-or-programs https://stock.noler.com/us/stock/aratana-therapeutics-inc/inventory-raw-materials-and-supplies https://stock.noler.com/us/stock/aratana-therapeutics-inc/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/aratana-therapeutics-inc/inventory-work-in-process https://stock.noler.com/us/stock/aratana-therapeutics-inc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/aratana-therapeutics-inc/inventory-write-down https://stock.noler.com/us/stock/aratana-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/aratana-therapeutics-inc/investments-fair-value-disclosure https://stock.noler.com/us/stock/aratana-therapeutics-inc/lease-and-rental-expense https://stock.noler.com/us/stock/aratana-therapeutics-inc/leasehold-improvements-gross https://stock.noler.com/us/stock/aratana-therapeutics-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/aratana-therapeutics-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/aratana-therapeutics-inc/level-3-liability-change https://stock.noler.com/us/stock/aratana-therapeutics-inc/level-3-liability-gain-loss-included-in-earnings https://stock.noler.com/us/stock/aratana-therapeutics-inc/level-3-liability-purchases https://stock.noler.com/us/stock/aratana-therapeutics-inc/level-3-liability-settlements https://stock.noler.com/us/stock/aratana-therapeutics-inc/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/aratana-therapeutics-inc/liabilities-other-than-longterm-debt-noncurrent https://stock.noler.com/us/stock/aratana-therapeutics-inc/license-and-services-revenue https://stock.noler.com/us/stock/aratana-therapeutics-inc/licenses-revenue https://stock.noler.com/us/stock/aratana-therapeutics-inc/line-of-credit-facility-amount-outstanding https://stock.noler.com/us/stock/aratana-therapeutics-inc/line-of-credit-facility-current-borrowing-capacity https://stock.noler.com/us/stock/aratana-therapeutics-inc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/aratana-therapeutics-inc/line-of-credit-facility-periodic-payment-interest https://stock.noler.com/us/stock/aratana-therapeutics-inc/line-of-credit-facility-remaining-borrowing-capacity https://stock.noler.com/us/stock/aratana-therapeutics-inc/loans-payable https://stock.noler.com/us/stock/aratana-therapeutics-inc/loans-payable-current https://stock.noler.com/us/stock/aratana-therapeutics-inc/long-term-loans-payable https://stock.noler.com/us/stock/aratana-therapeutics-inc/machinery-and-equipment-gross https://stock.noler.com/us/stock/aratana-therapeutics-inc/marketable-securities-current https://stock.noler.com/us/stock/aratana-therapeutics-inc/marketable-securities-gain-loss-excluding-other-than-temporary-impairments https://stock.noler.com/us/stock/aratana-therapeutics-inc/marketable-securities-noncurrent https://stock.noler.com/us/stock/aratana-therapeutics-inc/marketable-securities-unrealized-gain-loss https://stock.noler.com/us/stock/aratana-therapeutics-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/aratana-therapeutics-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/aratana-therapeutics-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/aratana-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/aratana-therapeutics-inc/net-income https://stock.noler.com/us/stock/aratana-therapeutics-inc/net-income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/aratana-therapeutics-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/aratana-therapeutics-inc/new-accounting-pronouncement-or-change-in-accounting-principle-effect-of-adoption-quantification https://stock.noler.com/us/stock/aratana-therapeutics-inc/noncash-or-part-noncash-acquisition-debt-assumed https://stock.noler.com/us/stock/aratana-therapeutics-inc/noncash-or-part-noncash-acquisition-noncash-financial-or-equity-instrument-consideration-warrants-issued https://stock.noler.com/us/stock/aratana-therapeutics-inc/noncash-or-part-noncash-acquisition-other-liabilities-assumed https://stock.noler.com/us/stock/aratana-therapeutics-inc/notes-payable-current https://stock.noler.com/us/stock/aratana-therapeutics-inc/number-of-operating-segments https://stock.noler.com/us/stock/aratana-therapeutics-inc/number-of-reportable-segments https://stock.noler.com/us/stock/aratana-therapeutics-inc/number-of-reporting-units https://stock.noler.com/us/stock/aratana-therapeutics-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/aratana-therapeutics-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/aratana-therapeutics-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-2 https://stock.noler.com/us/stock/aratana-therapeutics-inc/oci-net-of-tax https://stock.noler.com/us/stock/aratana-therapeutics-inc/oci-reclassification-adjustment-from-aoci-for-sale-of-securities-net-of-tax https://stock.noler.com/us/stock/aratana-therapeutics-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/aratana-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/aratana-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/aratana-therapeutics-inc/operating-income https://stock.noler.com/us/stock/aratana-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/aratana-therapeutics-inc/operating-lease-cost https://stock.noler.com/us/stock/aratana-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/aratana-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/aratana-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/aratana-therapeutics-inc/operating-lease-payments https://stock.noler.com/us/stock/aratana-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/aratana-therapeutics-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/aratana-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/aratana-therapeutics-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/aratana-therapeutics-inc/operating-lease-payments-due-in-four-and-five-years https://stock.noler.com/us/stock/aratana-therapeutics-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/aratana-therapeutics-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/aratana-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/aratana-therapeutics-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/aratana-therapeutics-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/aratana-therapeutics-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/aratana-therapeutics-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/aratana-therapeutics-inc/other-current-assets https://stock.noler.com/us/stock/aratana-therapeutics-inc/other-current-liabilities https://stock.noler.com/us/stock/aratana-therapeutics-inc/other-income https://stock.noler.com/us/stock/aratana-therapeutics-inc/other-income-2 https://stock.noler.com/us/stock/aratana-therapeutics-inc/other-liabilities-and-deferred-revenue-noncurrent https://stock.noler.com/us/stock/aratana-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/aratana-therapeutics-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/aratana-therapeutics-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/aratana-therapeutics-inc/other-significant-noncash-transaction-value-of-consideration-received https://stock.noler.com/us/stock/aratana-therapeutics-inc/other-sundry-liabilities-current https://stock.noler.com/us/stock/aratana-therapeutics-inc/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/aratana-therapeutics-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/aratana-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/aratana-therapeutics-inc/participating-securities-distributed-and-undistributed-earnings-loss-basic https://stock.noler.com/us/stock/aratana-therapeutics-inc/payments-for-derivative-instrument-investing-activities https://stock.noler.com/us/stock/aratana-therapeutics-inc/payments-of-debt-extinguishment-costs https://stock.noler.com/us/stock/aratana-therapeutics-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/aratana-therapeutics-inc/payments-of-merger-related-costs-financing-activities https://stock.noler.com/us/stock/aratana-therapeutics-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/aratana-therapeutics-inc/payments-to-acquire-businesses-gross https://stock.noler.com/us/stock/aratana-therapeutics-inc/payments-to-acquire-in-process-research-and-development https://stock.noler.com/us/stock/aratana-therapeutics-inc/payments-to-acquire-investments https://stock.noler.com/us/stock/aratana-therapeutics-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/aratana-therapeutics-inc/payments-to-acquire-other-investments https://stock.noler.com/us/stock/aratana-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/aratana-therapeutics-inc/preferred-stock-dividends-income-statement-impact https://stock.noler.com/us/stock/aratana-therapeutics-inc/preferred-stock-liquidation-preference-value https://stock.noler.com/us/stock/aratana-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/aratana-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/aratana-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/aratana-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/aratana-therapeutics-inc/preferred-stock-value https://stock.noler.com/us/stock/aratana-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/aratana-therapeutics-inc/prepaid-expense-current https://stock.noler.com/us/stock/aratana-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/aratana-therapeutics-inc/pretax-income-domestic https://stock.noler.com/us/stock/aratana-therapeutics-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/aratana-therapeutics-inc/proceeds-from-debt-net-of-issuance-costs https://stock.noler.com/us/stock/aratana-therapeutics-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/aratana-therapeutics-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/aratana-therapeutics-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/aratana-therapeutics-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans https://stock.noler.com/us/stock/aratana-therapeutics-inc/proceeds-from-repayments-of-notes-payable https://stock.noler.com/us/stock/aratana-therapeutics-inc/proceeds-from-sale-and-maturity-of-held-to-maturity-securities https://stock.noler.com/us/stock/aratana-therapeutics-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/aratana-therapeutics-inc/proceeds-from-sale-maturity-and-collections-of-investments https://stock.noler.com/us/stock/aratana-therapeutics-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/aratana-therapeutics-inc/proceeds-from-sale-of-restricted-investments https://stock.noler.com/us/stock/aratana-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/aratana-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/aratana-therapeutics-inc/profit-loss https://stock.noler.com/us/stock/aratana-therapeutics-inc/property-plant-and-equipment-disposals https://stock.noler.com/us/stock/aratana-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/aratana-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/aratana-therapeutics-inc/public-float https://stock.noler.com/us/stock/aratana-therapeutics-inc/related-party-transaction-selling-general-and-administrative-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/aratana-therapeutics-inc/repayments-of-debt https://stock.noler.com/us/stock/aratana-therapeutics-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/aratana-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/aratana-therapeutics-inc/research-and-development-asset-acquired-other-than-through-acquisition-written-off https://stock.noler.com/us/stock/aratana-therapeutics-inc/research-and-development-expense-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/aratana-therapeutics-inc/research-and-development-in-process https://stock.noler.com/us/stock/aratana-therapeutics-inc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/aratana-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/aratana-therapeutics-inc/revenue https://stock.noler.com/us/stock/aratana-therapeutics-inc/royalty-expense https://stock.noler.com/us/stock/aratana-therapeutics-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/aratana-therapeutics-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/aratana-therapeutics-inc/sales-revenue-net https://stock.noler.com/us/stock/aratana-therapeutics-inc/sga-expense https://stock.noler.com/us/stock/aratana-therapeutics-inc/share-price https://stock.noler.com/us/stock/aratana-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/aratana-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/aratana-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/aratana-therapeutics-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/aratana-therapeutics-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/aratana-therapeutics-inc/shares-issued-value-issued-for-services https://stock.noler.com/us/stock/aratana-therapeutics-inc/shares-issued-value-stock-dividend https://stock.noler.com/us/stock/aratana-therapeutics-inc/shares-paid-for-tax-withholding-for-share-based-compensation https://stock.noler.com/us/stock/aratana-therapeutics-inc/short-term-investments https://stock.noler.com/us/stock/aratana-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/aratana-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/aratana-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/aratana-therapeutics-inc/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/aratana-therapeutics-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/aratana-therapeutics-inc/stock-award-rsu-vested-in-period-total-fair-value https://stock.noler.com/us/stock/aratana-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/aratana-therapeutics-inc/stock-compensation-allocation-of-recognized-period-costs-capitalized-amount https://stock.noler.com/us/stock/aratana-therapeutics-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/aratana-therapeutics-inc/stock-compensation-unrecognized-cost-share-based-awards-other-than-options https://stock.noler.com/us/stock/aratana-therapeutics-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/aratana-therapeutics-inc/stock-granted-value-share-based-compensation https://stock.noler.com/us/stock/aratana-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/aratana-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/aratana-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities-net-of-adjustments https://stock.noler.com/us/stock/aratana-therapeutics-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/aratana-therapeutics-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/aratana-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/aratana-therapeutics-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/aratana-therapeutics-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/aratana-therapeutics-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/aratana-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/aratana-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/aratana-therapeutics-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/aratana-therapeutics-inc/stock-split-ratio https://stock.noler.com/us/stock/aratana-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/aratana-therapeutics-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/aratana-therapeutics-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/aratana-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/aratana-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/aratana-therapeutics-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/aratana-therapeutics-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/aratana-therapeutics-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/aratana-therapeutics-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/aratana-therapeutics-inc/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/aratana-therapeutics-inc/total-assets https://stock.noler.com/us/stock/aratana-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/aratana-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/aratana-therapeutics-inc/total-long-term-debt https://stock.noler.com/us/stock/aratana-therapeutics-inc/treasury-stock-acquired-average-cost-per-share https://stock.noler.com/us/stock/aratana-therapeutics-inc/treasury-stock-shares https://stock.noler.com/us/stock/aratana-therapeutics-inc/treasury-stock-value https://stock.noler.com/us/stock/aratana-therapeutics-inc/undistributed-earnings-loss-allocated-to-participating-securities-basic https://stock.noler.com/us/stock/aratana-therapeutics-inc/unrealized-gain-loss-on-derivatives-and-commodity-contracts https://stock.noler.com/us/stock/aratana-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/aratana-therapeutics-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/aratana-therapeutics-inc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/aratana-therapeutics-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/aratana-therapeutics-inc/variable-interest-entity-initial-consolidation-gain-or-loss https://stock.noler.com/us/stock/aratana-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted